Value through Innovation27 July 2016

Clinical Study Results

  • MOTENS ® - Angina Pectoris
    Clinical Study Number 231.339
    Study Indication Angina Pectoris
    Product MOTENS ®
    Generic Name Lacidipine
    Lab Code
    Clinical Phase IIb
    Study Title

    A randomised, double-blind, placebo-controlled, multi-centre, parallel group, dose ranging study to investigate the efficacy and safety of lacidipine in chronic stable angina. Lacidipine In Stable Angina (LISA)

    Study Document Trial synopsis 231.339 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.